$DOX

Amdocs earnings matched, revenue was in line with estimates

Amdocs (DOX) reported Q4 EPS of $1.98, matching estimates, with revenue at $1.19B, also in line. The stock is up 6.7% over 3 months but down 25.18% over 12 months. InvestingPro rates its financial health as 'good performance'.

Original reporting
Published Nov 3, 2026, 10:13 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 3, 2026, 10:22 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$DOX
Neutral
medium confidence
Mentioned
$DOX
Relevance
7/10
AlphAI data visualization · based on investing.com
Decision brief

The 30-second read

$DOXNeutralLow
01

Why it matters

The earnings release provides the first public disclosure of the quarter's financials, but the lack of surprise limits trading opportunities.

02

Market read

In‑line earnings for a mid‑cap telecom‑software firm; limited immediate market impact.

03

What to watch

Potential upside from upcoming contract announcements not covered in this release.

Relevance 7/10Novelty 7/10Timing: post‑market release

Background

Amdocs (NASDAQ:DOX) posted its fourth‑quarter earnings, matching consensus estimates for both EPS and revenue.

Company-level read

Ticker impact

$DOXNeutralMedium confidence
Context

Amdocs reported Q4 EPS of $1.98 and revenue of $1.19B, both exactly matching analyst estimates.

Expected impact

little movement as results match expectations

Evidence & confidence

The numbers are a first‑time disclosure but they confirm consensus, limiting upside or downside pressure.

Market effects

Telecom‑software sector sees no immediate shift; peers likely to trade flat.

U.S. market impact minimal given in‑line results.

Limited global relevance; Amdocs is a niche player.

Counterpoint

If investors anticipate a beat, the in‑line result could trigger a short‑cover rally.

Key entities

  • Amdocs

    Provider of software and services to communications and media companies.

Related articles

$DOXHighAI 9/10

Amdocs (DOX) Q4 2026 Earnings Call Transcript

Amdocs (DOX) announced an 8-year deal with AT&T and other strategic agreements with VEON, Globe, and VodafoneThree to adopt its AOS technology. The company also acquired EIS, an insurance software provider, for $340M. Amdocs plans to expand into the insurance market and has optimized its portfolio to focus on its agentic strategy. The company reported progress in internal transformation and provided FY2027 revenue growth guidance.

$DOXMedAI 8/10

Amdocs share price tanks as T-Mobile US dispute weighs heavily

Amdocs' share price dropped 42% after reporting a 3.6% revenue rise to $4.7bn, due to a contract dispute with T-Mobile US. The dispute may lead to arbitration or legal action, and Amdocs expects a 7-11% revenue decline in the coming year. Despite this, Amdocs secured new contracts with Vodafone, AT&T, and others, and acquired EIS for $340m to expand into insurance technology.

$DOXHighAI 9/10

Amdocs drama: Stock crashes 45%

Amdocs' stock fell 45% after hours due to a weak 2027 forecast tied to a legal dispute with T-Mobile. The company reported a 9.6% drop in its 12-month order backlog to $3.5B and annual revenue of $4.7B, up 3.5%. Amdocs also announced a new contract with AT&T and acquired EIS for $340M to expand into insurance.

$DOXHighAI 9/10

Why is Amdocs stock cratering 40% today?

Amdocs stock fell 39.4% to $37.83 after issuing a weak fiscal 2027 outlook due to a legal dispute with T-Mobile, its largest customer. Q4 2026 results met expectations, but FY2027 revenue is projected to decline 14.3%-17.9% and adjusted EPS to fall 26%-30%. Oppenheimer downgraded the stock, and analysts revised earnings forecasts downward. The company also announced a $340M acquisition, adding to financial pressures.